Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Infectious Diseases Market Research

Global Hospital Acquired Infections Therapeutic Databank Market Report

Best Price Guarantee Length Publisher Published Date SKU
from $2,000 100 Pages Magna Intelligence April, 2024 MAIN18750124
Best Price Guarantee
Price from $2,000
Length 100 Pages
Publisher Magna Intelligence
Published Date April, 2024
SKU MAIN18750124

Global Hospital Acquired Infections Therapeutic Databank Market Report


The Hospital Acquired Infections Therapeutic market was valued at $11,253.6 Million in 2022, and is projected to reach $13,433.9 Million by 2031 growing at a CAGR of 2.02% from 2023 to 2031. Antibacterial Drugs segment is expected to be the highest contributor to this market, with $9,937.3 Million in 2022, and is anticipated to reach $11,555.8 Million by 2031, registering a CAGR of 1.73%. Antifungal Drugs segment is anticipated to reach $472.2 Million by 2031 with the highest CAGR of 6.34%. Antibacterial Drugs and Antiviral Drugs segments collectively expected to account for about 97.6% share of the Hospital Acquired Infections Therapeutic market in 2022, with the former constituting around 88.3% share. Antifungal Drugs and Antiviral Drugs segments are expected to witness significant growth rates at a CAGR of 6.34% and 3.37% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 11.7% in the overall Hospital Acquired Infections Therapeutic market in 2022, and is anticipated to reach 14.0% by 2031.


1. Global Hospital Acquired Infections Therapeutic Market, By Drug Class
1.1. Overview
1.2. Antibacterial Drugs
1.2.1 Antibacterial Drugs Market, By Region
1.2.1.1 North America Antibacterial Drugs Market, By Country
1.2.1.2 Europe Antibacterial Drugs Market, By Country
1.2.1.3 Asia-Pacific Antibacterial Drugs Market, By Country
1.2.1.4 Rest of World Antibacterial Drugs Market, By Country
1.3. Antiviral Drugs
1.3.1 Antiviral Drugs Market, By Region
1.3.1.1 North America Antiviral Drugs Market, By Country
1.3.1.2 Europe Antiviral Drugs Market, By Country
1.3.1.3 Asia-Pacific Antiviral Drugs Market, By Country
1.3.1.4 Rest of World Antiviral Drugs Market, By Country
1.4. Antifungal Drugs
1.4.1 Antifungal Drugs Market, By Region
1.4.1.1 North America Antifungal Drugs Market, By Country
1.4.1.2 Europe Antifungal Drugs Market, By Country
1.4.1.3 Asia-Pacific Antifungal Drugs Market, By Country
1.4.1.4 Rest of World Antifungal Drugs Market, By Country
2. Global Hospital Acquired Infections Therapeutic Market, By Infection Type
2.1. Overview
2.2. Urinary Tract Infections
2.2.1 Urinary Tract Infections Market, By Region
2.2.1.1 North America Urinary Tract Infections Market, By Country
2.2.1.2 Europe Urinary Tract Infections Market, By Country
2.2.1.3 Asia-Pacific Urinary Tract Infections Market, By Country
2.2.1.4 Rest of World Urinary Tract Infections Market, By Country
2.3. Ventilator-associated Pneumonia
2.3.1 Ventilator-associated Pneumonia Market, By Region
2.3.1.1 North America Ventilator-associated Pneumonia Market, By Country
2.3.1.2 Europe Ventilator-associated Pneumonia Market, By Country
2.3.1.3 Asia-Pacific Ventilator-associated Pneumonia Market, By Country
2.3.1.4 Rest of World Ventilator-associated Pneumonia Market, By Country
2.4. Surgical Site Infections
2.4.1 Surgical Site Infections Market, By Region
2.4.1.1 North America Surgical Site Infections Market, By Country
2.4.1.2 Europe Surgical Site Infections Market, By Country
2.4.1.3 Asia-Pacific Surgical Site Infections Market, By Country
2.4.1.4 Rest of World Surgical Site Infections Market, By Country
2.5. Bloodstream Infections
2.5.1 Bloodstream Infections Market, By Region
2.5.1.1 North America Bloodstream Infections Market, By Country
2.5.1.2 Europe Bloodstream Infections Market, By Country
2.5.1.3 Asia-Pacific Bloodstream Infections Market, By Country
2.5.1.4 Rest of World Bloodstream Infections Market, By Country
2.6. Other Hospital Infections
2.6.1 Other Hospital Infections Market, By Region
2.6.1.1 North America Other Hospital Infections Market, By Country
2.6.1.2 Europe Other Hospital Infections Market, By Country
2.6.1.3 Asia-Pacific Other Hospital Infections Market, By Country
2.6.1.4 Rest of World Other Hospital Infections Market, By Country
3. Global Hospital Acquired Infections Therapeutic Market, By Region
3.1. Overview
3.2. North America
3.2.1 North America Hospital Acquired Infections Therapeutic Market, By Drug Class
3.2.2 North America Hospital Acquired Infections Therapeutic Market, By Infection Type
3.2.3 North America Hospital Acquired Infections Therapeutic Market, By Country
3.2.3.1 U.S.
3.2.3.1.1 U.S. Hospital Acquired Infections Therapeutic Market, By Drug Class
3.2.3.1.2 U.S. Hospital Acquired Infections Therapeutic Market, By Infection Type
3.2.3.2 Canada
3.2.3.2.1 Canada Hospital Acquired Infections Therapeutic Market, By Drug Class
3.2.3.2.2 Canada Hospital Acquired Infections Therapeutic Market, By Infection Type
3.3. Europe
3.3.1 Europe Hospital Acquired Infections Therapeutic Market, By Drug Class
3.3.2 Europe Hospital Acquired Infections Therapeutic Market, By Infection Type
3.3.3 Europe Hospital Acquired Infections Therapeutic Market, By Country
3.3.3.1 Germany
3.3.3.1.1 Germany Hospital Acquired Infections Therapeutic Market, By Drug Class
3.3.3.1.2 Germany Hospital Acquired Infections Therapeutic Market, By Infection Type
3.3.3.2 U.K.
3.3.3.2.1 U.K. Hospital Acquired Infections Therapeutic Market, By Drug Class
3.3.3.2.2 U.K. Hospital Acquired Infections Therapeutic Market, By Infection Type
3.3.3.3 France
3.3.3.3.1 France Hospital Acquired Infections Therapeutic Market, By Drug Class
3.3.3.3.2 France Hospital Acquired Infections Therapeutic Market, By Infection Type
3.3.3.4 Italy
3.3.3.4.1 Italy Hospital Acquired Infections Therapeutic Market, By Drug Class
3.3.3.4.2 Italy Hospital Acquired Infections Therapeutic Market, By Infection Type
3.3.3.5 Spain
3.3.3.5.1 Spain Hospital Acquired Infections Therapeutic Market, By Drug Class
3.3.3.5.2 Spain Hospital Acquired Infections Therapeutic Market, By Infection Type
3.3.3.6 Rest of Europe
3.3.3.6.1 Rest of Europe Hospital Acquired Infections Therapeutic Market, By Drug Class
3.3.3.6.2 Rest of Europe Hospital Acquired Infections Therapeutic Market, By Infection Type
3.4. Asia-Pacific
3.4.1 Asia-Pacific Hospital Acquired Infections Therapeutic Market, By Drug Class
3.4.2 Asia-Pacific Hospital Acquired Infections Therapeutic Market, By Infection Type
3.4.3 Asia-Pacific Hospital Acquired Infections Therapeutic Market, By Country
3.4.3.1 China
3.4.3.1.1 China Hospital Acquired Infections Therapeutic Market, By Drug Class
3.4.3.1.2 China Hospital Acquired Infections Therapeutic Market, By Infection Type
3.4.3.2 Japan
3.4.3.2.1 Japan Hospital Acquired Infections Therapeutic Market, By Drug Class
3.4.3.2.2 Japan Hospital Acquired Infections Therapeutic Market, By Infection Type
3.4.3.3 South Korea
3.4.3.3.1 South Korea Hospital Acquired Infections Therapeutic Market, By Drug Class
3.4.3.3.2 South Korea Hospital Acquired Infections Therapeutic Market, By Infection Type
3.4.3.4 India
3.4.3.4.1 India Hospital Acquired Infections Therapeutic Market, By Drug Class
3.4.3.4.2 India Hospital Acquired Infections Therapeutic Market, By Infection Type
3.4.3.5 Singapore
3.4.3.5.1 Singapore Hospital Acquired Infections Therapeutic Market, By Drug Class
3.4.3.5.2 Singapore Hospital Acquired Infections Therapeutic Market, By Infection Type
3.4.3.6 Rest of Asia
3.4.3.6.1 Rest of Asia Hospital Acquired Infections Therapeutic Market, By Drug Class
3.4.3.6.2 Rest of Asia Hospital Acquired Infections Therapeutic Market, By Infection Type
3.5. Rest of World
3.5.1 Rest of World Hospital Acquired Infections Therapeutic Market, By Drug Class
3.5.2 Rest of World Hospital Acquired Infections Therapeutic Market, By Infection Type
3.5.3 Rest of World Hospital Acquired Infections Therapeutic Market, By Country
3.5.3.1 Brazil
3.5.3.1.1 Brazil Hospital Acquired Infections Therapeutic Market, By Drug Class
3.5.3.1.2 Brazil Hospital Acquired Infections Therapeutic Market, By Infection Type
3.5.3.2 Mexico
3.5.3.2.1 Mexico Hospital Acquired Infections Therapeutic Market, By Drug Class
3.5.3.2.2 Mexico Hospital Acquired Infections Therapeutic Market, By Infection Type
3.5.3.3 South Africa
3.5.3.3.1 South Africa Hospital Acquired Infections Therapeutic Market, By Drug Class
3.5.3.3.2 South Africa Hospital Acquired Infections Therapeutic Market, By Infection Type
3.5.3.4 Australia
3.5.3.4.1 Australia Hospital Acquired Infections Therapeutic Market, By Drug Class
3.5.3.4.2 Australia Hospital Acquired Infections Therapeutic Market, By Infection Type
3.5.3.5 ROW Countries
3.5.3.5.1 ROW Countries Hospital Acquired Infections Therapeutic Market, By Drug Class
3.5.3.5.2 ROW Countries Hospital Acquired Infections Therapeutic Market, By Infection Type
ROW Countries Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD LIST OF TABLES
TABLE 1. Global Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 2. Antibacterial Drugs Market Value, By Region, 2022-2031, Million USD
TABLE 3. North America Antibacterial Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 4. Europe Antibacterial Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 5. Asia-Pacific Antibacterial Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 6. Rest of World Antibacterial Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 7. Antiviral Drugs Market Value, By Region, 2022-2031, Million USD
TABLE 8. North America Antiviral Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 9. Europe Antiviral Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 10. Asia-Pacific Antiviral Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 11. Rest of World Antiviral Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 12. Antifungal Drugs Market Value, By Region, 2022-2031, Million USD
TABLE 13. North America Antifungal Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 14. Europe Antifungal Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 15. Asia-Pacific Antifungal Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 16. Rest of World Antifungal Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 17. Global Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 18. Urinary Tract Infections Market Value, By Region, 2022-2031, Million USD
TABLE 19. North America Urinary Tract Infections Market Value, By Country, 2022-2031, Million USD
TABLE 20. Europe Urinary Tract Infections Market Value, By Country, 2022-2031, Million USD
TABLE 21. Asia-Pacific Urinary Tract Infections Market Value, By Country, 2022-2031, Million USD
TABLE 22. Rest of World Urinary Tract Infections Market Value, By Country, 2022-2031, Million USD
TABLE 23. Ventilator-associated Pneumonia Market Value, By Region, 2022-2031, Million USD
TABLE 24. North America Ventilator-associated Pneumonia Market Value, By Country, 2022-2031, Million USD
TABLE 25. Europe Ventilator-associated Pneumonia Market Value, By Country, 2022-2031, Million USD
TABLE 26. Asia-Pacific Ventilator-associated Pneumonia Market Value, By Country, 2022-2031, Million USD
TABLE 27. Rest of World Ventilator-associated Pneumonia Market Value, By Country, 2022-2031, Million USD
TABLE 28. Surgical Site Infections Market Value, By Region, 2022-2031, Million USD
TABLE 29. North America Surgical Site Infections Market Value, By Country, 2022-2031, Million USD
TABLE 30. Europe Surgical Site Infections Market Value, By Country, 2022-2031, Million USD
TABLE 31. Asia-Pacific Surgical Site Infections Market Value, By Country, 2022-2031, Million USD
TABLE 32. Rest of World Surgical Site Infections Market Value, By Country, 2022-2031, Million USD
TABLE 33. Bloodstream Infections Market Value, By Region, 2022-2031, Million USD
TABLE 34. North America Bloodstream Infections Market Value, By Country, 2022-2031, Million USD
TABLE 35. Europe Bloodstream Infections Market Value, By Country, 2022-2031, Million USD
TABLE 36. Asia-Pacific Bloodstream Infections Market Value, By Country, 2022-2031, Million USD
TABLE 37. Rest of World Bloodstream Infections Market Value, By Country, 2022-2031, Million USD
TABLE 38. Other Hospital Infections Market Value, By Region, 2022-2031, Million USD
TABLE 39. North America Other Hospital Infections Market Value, By Country, 2022-2031, Million USD
TABLE 40. Europe Other Hospital Infections Market Value, By Country, 2022-2031, Million USD
TABLE 41. Asia-Pacific Other Hospital Infections Market Value, By Country, 2022-2031, Million USD
TABLE 42. Rest of World Other Hospital Infections Market Value, By Country, 2022-2031, Million USD
TABLE 43. Global Hospital Acquired Infections Therapeutic Market Value, By Region, 2022-2031, Million USD
TABLE 44. North America Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 45. North America Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 46. North America Hospital Acquired Infections Therapeutic Market Value, By Country, 2022-2031, Million USD
TABLE 47. U.S. Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 48. U.S. Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 49. Canada Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 50. Canada Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 51. Europe Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 52. Europe Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 53. Europe Hospital Acquired Infections Therapeutic Market Value, By Country, 2022-2031, Million USD
TABLE 54. Germany Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 55. Germany Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 56. U.K. Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 57. U.K. Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 58. France Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 59. France Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 60. Italy Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 61. Italy Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 62. Spain Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 63. Spain Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 64. Rest of Europe Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 65. Rest of Europe Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 66. Asia-Pacific Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 67. Asia-Pacific Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 68. Asia-Pacific Hospital Acquired Infections Therapeutic Market Value, By Country, 2022-2031, Million USD
TABLE 69. China Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 70. China Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 71. Japan Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 72. Japan Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 73. South Korea Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 74. South Korea Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 75. India Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 76. India Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 77. Singapore Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 78. Singapore Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 79. Rest of Asia Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 80. Rest of Asia Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 81. Rest of World Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 82. Rest of World Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 83. Rest of World Hospital Acquired Infections Therapeutic Market Value, By Country, 2022-2031, Million USD
TABLE 84. Brazil Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 85. Brazil Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 86. Mexico Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 87. Mexico Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 88. South Africa Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 89. South Africa Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 90. Australia Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 91. Australia Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
TABLE 92. ROW Countries Hospital Acquired Infections Therapeutic Market Value, By Drug Class, 2022-2031, Million USD
TABLE 93. ROW Countries Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD
ROW Countries Hospital Acquired Infections Therapeutic Market Value, By Infection Type, 2022-2031, Million USD

$2,000
$3,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings